Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies

Blood

Volumn 102, Issue 5, 2003, Pages 1641-1648

  Jones, Barry ^a   Adams, Sharlene ^b   Miller, Glenn T ^b   Jesson, Michael I ^b   Watanabe, Takeshi ^b   Wallner, Barbara P ^b  

^a Point Therapeutics   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOBORONIC DIPEPTIDE; CYTOKINE; DIPEPTIDE; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; FIBROBLAST ACTIVATION PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 6; PROTEIN; TALABOSTAT; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL GROWTH; CELL REGENERATION; CELL RENEWAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACETYLATION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME BINDING; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REGULATORY MECHANISM; STROMA CELL;

EID: 0041828976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0208     Document Type: Article

References (39)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844-2853.
2. Socolovsky M, Constantinescu SN, Bergelson S, Sirotkin S, Lodish HF. Cytokines in hematopoiesis: specificity and redundancy in receptor function. Adv Protein Chem. 1998;52:141-198.
3. Whetton AD, Spooner E. Role of cytokines and extracellular matrix in the regulation of haemopoietic stem cells. Curr Opin Cell Biol. 1998;10:721-726.
4. Miller CL, Eaves CJ. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting activity. Proc Natl Acad Sci U S A. 1997;94:13648-13653.
5. +-selected human peripheral blood progenitor cells. Blood. 1994;84:2898-2903.
6. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78:2791-2808.
7. Jelkmann W, Hellwig-Burgel T. Biology of erythropoietin. Adv Exp Med Biol. 2001;502:169-187.
8. Adamson JW, Eschbach JW. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin. Annu Rev Med. 1990;41:349-360.
9. Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med. 1997;336:1776-1780.
10. Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood. 2000;95:19-29.
11. Demuth H-U, Heins J. Catalytic mechanism of dipeptidyl peptidase IV. In: Fleischer B, ed. Dipeptidyl Peptidase IV (CD26) in Metabolism and Immune Response. Austin, TX: RG Landes; 1995:1-34.
12. De Meester I, Korom S, Van Damme J, Scharpe S. CD26, let it cut of cut it down. Immunol Today. 1999;20:367-375.
13. Yaron A, Naider F. Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol. 1993;28:31-81.
14. Niedermeyer J, Enenkel B, Park JE, et al. Mouse fibroblast-activation protein Conserved Fap gene organization and biochemical function as a serine protease. Eur J Biochem. 1998;254:650-654.
15. Sedo A, Malik R. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? Biochim Biophys Acta. 2001;1550:107-116.
16. von Bonin A, Huhn J, Fleischer B. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol Rev. 1998;161:43-53.
17. Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev. 1998;161:55-70.
18. Bristol LA, Bachovchin W, Takacs L. Inhibition of CD26 enzyme activity with Pro-boropro stimulates rat granulocyte/macrophage colony formation and thymocyte proliferation in vitro. Blood. 1995;85:3602-3609.
19. Coutts SJ, Kelly TA, Snow RJ, et al. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV, 1: variation of the P2 position of Xaa-boroPro dipeptides. J Med Chem. 1996;39:2087-2094.
20. Kubota T, Flenke GR, Bachovchin WW, Stollar BD. Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol. 1992;89:192-197.
21. Scanlan MJ, Mohan Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A. 1994;91:5657-5661.
22. Marguet D, Baggio L, Kobayashi T, et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A. 2000;97:6874-6879.
23. Bachovchin WW, Plaut AG, Flentke GR, Lynch M, Kettner CA. Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Hemophilus influenzae by peptide prolyl boronic acids. J Biol Chem. 1990;265:3738-3743.
24. Sutherland HJ, Landsdorp PM, Henkelman DH, Eaves AC, Eaves CJ. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 1990;87:3584-3488.
25. Flentke GR, Munoz E, Huber BT, Plaut AG, Kettner CA, Bachovchin WW. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci U S A. 1991;88:1556-1559.
26. Deryugina EI, Muller-Sieburg CE. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development. Crit Rev Immunol. 1993;13:115-150.
27. Dexter TM, Moore MAS, Sheridan APC. Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semi-allogeneic bone marrow chimeras in vitro. J Exp Med. 1977;145:1612-1616.
28. Goldstein LA, Ghersi G, Pineiro-Sanchez ML, et al. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta. 1997;1361:11-19.
29. Park JE, Lenter MC, Zimmerman RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274:36505-36512.
30. Puschel G, Mentlein R, Heymann E. Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur J Biochem. 1982;126:359-365.
31. Tsuji E, Misumi Y, Fujiwara T, Takami N, Ogata S, Ikehara Y. An active site mutation (Gly633 to Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum. Biochemistry. 1992;31:11921-11927.
32. Hangoc G, Tinggui Y, Cooper S, Schendel P, Yang Y-C, Broxmeyer HE. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood. 1993;81:965-972.
33. Molineux G, Pojda Z, Dexter TM. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood. 1990;75:563-569.
34. Hara H, Ogawa M. Erythropoietin precursors in mice with phenylhydrazine-induced anemia. Am J Hematol. 1976;1:453-458.
35. Rawlings ND, Barrett AJ. Dipeptidyl-peptidase II is related to lysosomal Pro-X carboxypeptidase. Biochim Biophys Acta. 1996;1298:1-3.
36. Underwood R, Chiravuri M, Lee H, et al. Sequence, purification and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem. 1999;274:34053-34058.
37. Duke-Cohan JS, Gu J, McLaughlin DF, Xu Y, Freeman GJ, Schlossman SF. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc Natl Acad Sci U S A. 1998;95:11336-11341.
38. Gunn TM, Miller KA, He L, et al. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 1999;398:152-156.
39. Ouriaghli FE, Fujiwara H, Melenhorst JJ, Sconocchia G, Hensel N, Barret AJ. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications in the regulation of granulopoiesis. Blood. 2003;101:1752-1758.